Video

Emily Johnston Discusses End-of-Life Care for Younger Patients

Emily Johnston, hematology/oncology fellow at the Lucile Packard Children's Hospital Stanford, discusses intensity of end-of-life care for the adolescent and young adult (AYA) cancer population.

Emily Johnston, hematology/oncology fellow at the Lucile Packard Children's Hospital Stanford, discusses intensity of end-of-life care for the adolescent and young adult (AYA) cancer population.

Most AYA patients involved in a study conducted at Lucile Packard Children's Hospital received at least one intensive end-of-life intervention, but statistics were not same across different populations. Johnston found that minorities received more end-of-life interventions than whites did, and patients who were not treated at a speciality hospital also had higher incidences of interventions.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.